Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, and Japan
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
Biocon Biologics earlier announced a settlement agreement in the United States for a Bmab 1200 launch no later than February 22, 2025
Also received tentative approval for 137 mg
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
Rad-Sure blood irradiation indicators are FDA 510 (k) cleared medical devices that offer positive visual verification of irradiation at the minimum specified dose
Monkeypox infections are usually self-limiting lasting between 2-4 weeks and patients generally recover with supportive management
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
The partnership marks a significant milestone in integrating digital health education into medical curricula
This project is supported by the Irish Government through IDA Ireland
Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)
Subscribe To Our Newsletter & Stay Updated